Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precise definition of the breakpoints of an apparently balanced translocation between chromosome 3q26 and chromosome 7q36: Role of KMT2C disruption. | Congenit Anom (Kyoto) | 2023 | 36946065 | PubTator, text mining | PubMed |
| Comprehensive analysis of autophagy-related clusters and individual risk model for immunotherapy response prediction in gastric cancer. | Front Oncol | 2023 | 36937439 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 36937425 | PubTator, text mining | PubMed |
| Research progress in molecular pathology markers in medulloblastoma. | Explor Target Antitumor Ther | 2023 | 36937322 | PubTator, text mining | PubMed |
| TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy. | J Biol Chem | 2023 | 36935008 | PubTator, text mining | PubMed |
| Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer. | Cell Mol Life Sci | 2023 | 36933062 | PubTator, text mining | PubMed |
| A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. | Clin Cancer Res | 2023 | 36928921 | PubTator, text mining | PubMed |
| A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer. | Nat Med | 2023 | 36928816 | PubTator, text mining | PubMed |
| Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. | World J Surg Oncol | 2023 | 36927438 | PubTator, text mining | PubMed |
| Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies. | Front Cell Dev Biol | 2023 | 36923252 | PubTator, text mining | PubMed |
| The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness. | Front Endocrinol (Lausanne) | 2023 | 36909339 | PubTator, text mining | PubMed |
| Atypical histone targets of PHD fingers. | J Biol Chem | 2023 | 36907441 | PubTator, text mining | PubMed |
| Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis. | Mol Cell Biochem | 2023 | 36905477 | PubTator, text mining | PubMed |
| Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36902450 | PubTator, text mining | PubMed |
| The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. | Int J Mol Sci | 2023 | 36902370 | PubTator, text mining | PubMed |
| Genomics-Driven Precision Medicine in Pediatric Solid Tumors. | Cancers (Basel) | 2023 | 36900212 | PubTator, text mining | PubMed |
| Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. | Cancers (Basel) | 2023 | 36900160 | PubTator, text mining | PubMed |
| PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. | Cells | 2023 | 36899918 | PubTator, text mining | PubMed |
| Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL. | Blood Adv | 2023 | 36897249 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers. | Mol Cancer | 2023 | 36882835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=37